Lacove 10 mg Injection 20 ml Substitute
by Others
by Others
by Others
by AYUR
by AYUR
by AYUR
by AYUR
Composition:
LACOSAMIDE-10MG
Uses:
<p>Lacove 10 mg Injection 20 ml is used in the treatment of focal (partial) seizures. The detailed uses of Lacove 10 mg Injection 20 ml are as follows:</p><ul><li><strong>Partial-onset (focal) seizures: </strong>Treats partial-onset (focal) seizures in both adults and children, helping to reduce abnormal brain activity.</li><li><strong>Generalised tonic-clonic seizures: </strong>Controls generalised tonic-clonic seizures, which cause loss of consciousness along with muscle stiffness and jerking movements.</li></ul>
Medicinal Benefits:
Lacove 10 mg Injection 20 ml belongs to the class of anticonvulsants used to treat partial onset seizures (seizures that affect only one portion of the brain) in adults and children one month or older who cannot take oral treatments. Lacove 10 mg Injection 20 ml is also used in conjunction with other medications to manage primary generalised tonic-clonic seizures.
Lacove 10 mg Injection 20 ml contains lacosamide, which treats seizures by decreasing disorganised electrical activity in the brain.
Coordination and walking issues normally improve within a few weeks. Inform your service provider if the problems persist.
Lacove 10 mg Injection 20 ml should be used with caution in patients who are taking drugs that influence cardiac conduction, such as sodium channel blockers, beta-blockers, calcium channel blockers, potassium channel blockers, and medications that lengthen the PR interval.
Your doctor can identify a seizure after hearing about your experience or the signs noted by others. Your doctor may recommend testing based on your symptoms and medical history. Brain imaging scans, blood tests, or a spinal tap may be used to determine the cause of your seizures.
In people with cardiac rhythm and conduction abnormalities, use Lacove 10 mg Injection 20 ml with caution. In patients with underlying proarrhythmic disorders or who are taking concomitant drugs that influence cardiac conduction, an ECG should be obtained before and after titration for steady-state maintenance; these patients should be regularly monitored.